Genetic Technologies (GENE) Short Interest Ratio & Short Volume → Watch this FREE trading tutorial while it’s still available (From InvestorPlace) (Ad) Free GENE Stock Alerts $2.25 +0.03 (+1.35%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Genetic Technologies Short Interest DataCurrent Short Volume15,700 sharesPrevious Short Volume11,500 sharesChange Vs. Previous Month+36.52%Dollar Volume Sold Short$51,417.50Short Interest Ratio / Days to Cover0.5Last Record DateApril 15, 2024Outstanding Shares3,850,000 sharesPercentage of Shares Shorted0.41%Today's Trading Volume27,393 sharesAverage Trading Volume29,068 sharesToday's Volume Vs. Average94% Short Selling Genetic Technologies ? Sign up to receive the latest short interest report for Genetic Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGENE Short Interest Over TimeGENE Days to Cover Over TimeGENE Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details Genetic Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202415,700 shares $51,417.50 +36.5%N/A0.5 $3.28 3/31/202411,500 shares $33,235.00 -58.5%N/A0.4 $2.89 3/15/202427,700 shares $74,513.00 -53.9%N/A0.9 $2.69 2/29/202460,100 shares $129,215.00 +114.6%N/A1.9 $2.15 2/15/202428,000 shares $58,100.00 -3.8%N/A1.2 $2.08 1/31/202429,100 shares $57,909.00 +3.6%N/A1.2 $1.99 Get the Latest News and Ratings for GENE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter. 1/15/202428,100 shares $66,878.00 +19.6%N/A1.2 $2.38 12/31/202323,500 shares $56,400.00 -19.8%N/A0.9 $2.40 12/15/202329,300 shares $87,314.00 -80.2%N/A1.3 $2.98 11/30/2023147,800 shares $539,543.90 -25.4%N/A1.2 $3.65 11/15/2023198,200 shares $139,889.56 -34.2%N/A1.8 $0.71 10/31/2023301,100 shares $213,449.79 +89.7%N/A2.6 $0.71 10/15/2023158,700 shares $107,550.99 -14.0%N/A1.3 $0.68 9/30/2023184,500 shares $140,699.70 -50.0%N/A1.8 $0.76 9/15/2023368,600 shares $319,760.50 +469.7%N/A3.4 $0.87 8/31/202364,700 shares $51,760.00 +22.3%N/A1 $0.80 8/15/202352,900 shares $37,559.00 -61.8%N/A0.6 $0.71 7/31/2023138,300 shares $116,172.00 -14.7%N/A1.3 $0.84 7/15/2023162,100 shares $148,045.93 +54.1%N/A1.4 $0.91 6/30/2023105,200 shares $87,400.16 +7.6%N/A0.9 $0.83 6/15/202397,800 shares $96,333.00 -53.7%N/A0.8 $0.99 5/31/2023211,200 shares $202,287.36 +161.7%N/A1.5 $0.96 5/15/202380,700 shares $76,665.00 No ChangeN/A0.4 $0.95 10/31/202269,800 shares $83,411.00 -14.8%N/A1.5 $1.20 10/15/202281,900 shares $95,823.00 +21.7%N/A1.5 $1.17 9/30/202267,300 shares $78,599.67 -20.9%N/A1.1 $1.17 9/15/202285,100 shares $128,501.00 +66.2%N/A1.1 $1.51 8/31/202251,200 shares $75,264.00 +16.9%N/A0.7 $1.47 8/15/202243,800 shares $72,270.00 +8.4%N/A0.6 $1.65 7/31/202240,400 shares $64,640.00 -15.0%N/A0.6 $1.60 7/15/202247,500 shares $68,875.00 -22.4%N/A0.8 $1.45 6/30/202261,200 shares $70,992.00 -13.6%N/A1.1 $1.16 6/15/202270,800 shares $80,004.00 -17.2%N/A1.4 $1.13 5/31/202285,500 shares $107,105.85 -21.2%N/A1.5 $1.25 5/15/2022108,500 shares $133,455.00 -19.6%N/A1.5 $1.23 4/30/2022134,900 shares $211,793.00 -12.8%N/A1.9 $1.57 4/15/2022154,700 shares $280,007.00 -23.4%N/A2.1 $1.81 3/31/2022202,000 shares $397,940.00 -38.2%N/A2.6 $1.97 3/15/2022326,600 shares $604,210.00 -6.9%N/A3.5 $1.85 2/28/2022350,900 shares $726,363.00 +23.5%N/A2.5 $2.07Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. GENE Short Interest - Frequently Asked Questions What is Genetic Technologies' current short interest? Short interest is the volume of Genetic Technologies shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 15,700 shares of GENE short. Learn More on Genetic Technologies' current short interest. Is Genetic Technologies' short interest increasing or decreasing? Genetic Technologies saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 15,700 shares, an increase of 36.5% from the previous total of 11,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Genetic Technologies' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Genetic Technologies: BioCardia, Inc. (1.01%), Organovo Holdings, Inc. (1.49%), Coeptis Therapeutics Holdings, Inc. (0.66%), Titan Pharmaceuticals, Inc. (1.72%), Creative Medical Technology Holdings, Inc. (1.76%), Fresh Tracks Therapeutics, Inc. (0.17%), Palisade Bio, Inc. (4.12%), TRACON Pharmaceuticals, Inc. (1.16%), Finch Therapeutics Group, Inc. (1.96%), Avalon GloboCare Corp. (2.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Genetic Technologies stock? Short selling GENE is an investing strategy that aims to generate trading profit from Genetic Technologies as its price is falling. GENE shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genetic Technologies? A short squeeze for Genetic Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GENE, which in turn drives the price of the stock up even further. How often is Genetic Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GENE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BioCardia Short Interest Organovo Short Interest Coeptis Therapeutics Short Interest Titan Pharmaceuticals Short Interest Creative Medical Technology Short Interest Fresh Tracks Therapeutics Short Interest Palisade Bio Short Interest TRACON Pharmaceuticals Short Interest Finch Therapeutics Group Short Interest Avalon GloboCare Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GENE) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceThe asset beating inflation by 4xColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits